Top Safest Companies To Watch For 2014

Source: StockMonkeys.com

Not all dividend stocks are created equal. Some offer monstrous 10% yields or more, but their share prices dwindle with each passing year.

With that in mind, I have identified two dividend stocks that offer above-average yields and have characteristics that suggest they should be safer than most massive yielders.

A niche New York bank
New York Community Bancorp (NYSE: NYCB  ) �is�one of the highest-yielding banks, and arguably one of the safest.

The bank focuses on lending to multifamily investors in the New York City area, where rents are seemingly always on the rise and demand for housing is permanently strong. Due to the underlying characteristics of the real estate market, the bank's credit metrics are often near the top of the industry, even during the depths of the financial crisis.

The stock is no slouch, though. Today's buyers will pay about 16 times last year's earnings. But because the bank pays out almost all of its income each year, the stock yields a respectable 6.7% dividend.

Top Penny Companies To Own In Right Now: Mimvi Inc (MIMV)

Mimvi, Inc., formerly Fashion Net, Inc., incorporated on August 7, 2007, is a development-stage Company. The Company is a technology company that develops advanced mobile apps, algorithms and technology for personalized search, recommendation and discovery services for the mobile application and social networking industry. Its personalization technology automates the organization of content connected to mobile applications and social networking applications. The Company has developed cognitive computing technology, which is the basis for its personalized search and recommendation platform. Mobile applications are the new Websites and mobile devices are the new browsers. In April 2013, Mimvi Inc acquired FanAppic. In May 2013, Mimvi Inc acquired AndroidRays. Effective July 2, 2013, Mimvi Inc acquired Adaptive Media Inc.

Specialized Web and Mobile Content Crawling and Aggregation Systems

The Company has developed technology that algorithmically targets, aggregates and monitors mobile application marketplaces from Apple, Google, Facebook and many other mobile and social platform providers. Its technology talks to sites like these to determine what content is available to better organize for the consumer. The technology does not store content but rather data related to the content that can be used to provide search, recommendation and discovery into these content storage sites. The specialized content aggregation systems target, aggregates and monitors social networking applications, iPhone an iPad apps, Android apps and other mobile application sites and marketplaces such as those provided by Facebook, Apple, Google and other mobile carriers and platforms. The Company technology generates data that enables advanced search, recommendation and discovery of all mobile apps found on the Web and on mobile operating systems.

Advanced Personalization, Recommendation, Automated Discovery and Matching Platforms

The Company�� personalization platforms consis! t of algorithms that contextually match content to consumer demand. These algorithms gather and generate context surround this content to provide advanced search, recommendation and discovery. Mimvi algorithms are based on vector space methods. Combining these methods results in the Mimvi personalized search, recommendation, discovery and matching platforms.

Vector Space Search Indexing Technology

The individual algorithmic component of vector space indexing enables the Company to generate context vectors of context for content such as mobile apps and websites. These vectors can be compared with other vectors for advanced contextual matching of mobile applications.

Vertical & Specialized Search Engines for Mobile and Social Networking Apps

Using the above mentioned methods and platforms, its technology includes vertical search and specialized search interfaces that focus on specific content providing a more targeted search result set.

Algorithm Development Services

The Company offers vector space algorithm development for customized solutions applied to mobile platforms, social networks, consumer websites and enterprise partners.

Powerful Application Programming Interfaces (APIs) for Partners & Third Parities

All of the Company�� technology platforms come enabled with APIs for efficient access and development of third party applications. This results in a broad ecosystem of close partners that benefit from its technology.

Simplified Scalable Consumer Mobile, Social and Web Offerings

The Company�� technology�� core is its ability to offer search and recommendation technology to mobile app stores and social networks in a scalable manor to maintain user retention while increasing user adoption. These abilities enable the consumer with simple and transparent access to personalized search, recommendation and discovery interfaces.

MimviLink

!

MimviL! ink enables mobile application developers and advertisers to match Web and Mobile Content to relevant mobile apps. MimviLink provides a way for consumers to access mobile applications related to the content they are viewing on the Web. MimviLink enables any company or individual with a mobile application to gain greater exposure for their mobile app by having it matched and displayed next to relevant Web and mobile content.

Algorithms, Technology & IP

Personalized Search & Recommendation Platforms that Index Mobile Applications and Social Networking Applications

The Company competes with Google, Apple, Baidu, Amazon, Yandex and NetFlix.

Advisors' Opinion:

• [By CRWE]

  Today, MIMV has shed (-0.36%) down -0.00 at $.11 with 78,697 shares in play thus far (ref. google finance Delayed: 1:19PM EDT October 3, 2013).

  Multi-channel audience and content monetization company Adaptive Media, a subsidiary of Mimvi, Inc., previously reported it has signed a Letter of Intent to acquire Ember, Inc. A Definitive Agreement in the all-stock transaction is expected to be signed in the fourth quarter of this year.

Top Safest Companies To Watch For 2014: M.D.C. Holdings Inc. (MDC)

M.D.C. Holdings, Inc., through its subsidiaries, engages in homebuilding and financial services businesses in the United States. Its homebuilding business activities include the purchase of finished lots or development of lots for the construction and sale of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name. The company�s financial services business activities comprise the origination of mortgage loans primarily for homebuyers; provision of third-party insurance products to homebuyers; and title agency services to homebuyers in Colorado, Florida, Maryland, Nevada, and Virginia. It also provides insurance coverage on homes sold and for work performed in completed subdivisions; and re-insures the claims. M.D.C. Holdings, Inc. was founded in 1972 and is based in Denver, Colorado.

Advisors' Opinion:

• [By Ben Levisohn]

  Combine that with an ever-so-slightly lower 10-year yield and you have a recipe for a housing rally. Hovnanian has gained 2.8% to $5.18, but that was nothing compared to other gainers today. PulteGroup (PHM) has jumped 8.1% to $16.73, MDC Holdings (MDC) has risen 7% to $29.59, D.R. Horton (DHI) has climbed 6.6% to $19.30 and the Ryland Group (RYL) is up 5.9% at $37.98.

• [By Dimitra DeFotis]

  Colleague Dave Englander recommended taking profits in another medical device maker, Boston Scientific (BSX) in mid-August. At the time, he noted that stock was up 107% since his favorable recommendation had appeared, outpacing the Standard & Poor’s 500 Index by 80 points. He noted Boston Scientific faces competition from St. Jude and Medtronic (MDC), and he said that the market for stents and defibrillators has stabilized but is “not likely to grow meaningfully.” �(See “Time to Sell These Winners,” Aug. 14, subscription required.)

• [By Lisa Levin]

  MDC Holdings (NYSE: MDC) shares fell 1.16% to touch a new 52-week low of $25.60. MDC Holdings' PEG ratio is 3.14.

  PDF Solutions (NASDAQ: PDFS) shares reached a new 52-week low of $12.91. PDF Solutions updated the status of certain contracts and announced the effect of the change in status on previously deferred costs and expected revenues.

Top Safest Companies To Watch For 2014: Infosys Technologies Limited(INFY)

Infosys Ltd. provides information technology (IT) and consulting services worldwide. It offers IT services, such as application, architecture, independent validation and testing, information management, infrastructure, packaged application, SOA, systems integration, and knowledge services; product engineering services, manufacturing process and plant solutions, and product lifecycle management services; and consulting services in the areas of information and technology strategies, product innovation, next generation commerce, process excellence, and learning and complex change. The company also provides business process outsourcing solutions in the areas of business platforms, customer service outsourcing, finance and accounting, human resources outsourcing, legal services, sales and fulfillment, and sourcing and procurement outsourcing. In addition, it offers collaborative analytics solutions; digital consumer platform; Finacle universal banking solution; iProwe, a Web ac cessibility assessment product; mConnect, a real-time enterprise middleware; and research and analytical support services. Further, the company offers unified communications and collaboration solution that streamlines business processes between employees, customers, and suppliers; iTransform that helps healthcare organizations accelerate transition to new platforms; and supply chain visibility and collaboration product suite. It serves aerospace and defense, airlines, automotive, banking, capital markets, communication services, consumer packaged goods, manufacturing, education, energy, healthcare, high technology, hospitality and leisure, insurance, life sciences, logistics and distribution, publishing, resources, utilities, and retail industries. Infosys Ltd. has a strategic partnership with Alstom SA. The company was formerly known as Infosys Technologies Limited and changed its name to Infosys Ltd. on June 16, 2011. Infosys Ltd. was founded in 1981 and is headquartered i n Bengaluru, India.

Advisors' Opinion:

• [By Aaron Smith]

  The government accused software developer Infosys (INFY) of using workers with B-1 visas, which only allow temporary entry into the U.S. for business purposes, to perform skilled labor jobs.

• [By Robert Martin]

  Infosys (INFY), Housing Development Finance and Reliance Industries LTD are the top three holdings, with weightings between 8% and 10.5%. Of course, just about any India ETF will have a heavy� allocation to Infosys and Reliance. However, INDA dedicates a lower percentage to energy than some of the alternatives, and instead leans more on IT and consumer spending.

• [By Dan Caplinger]

  Overall, the most popular emerging market ETFs experienced much sharper declines than the less-than-1% drop the Dow posted this week. Vanguard Emerging Markets (NYSEMKT: VWO  ) and iShares Emerging Markets (NYSEMKT: EEM  ) were both down just under 3% for the week. But when you drill down to look for particular culprits in the emerging markets, you don't have to look very far to find that it was generally a broad-based decline:

  In China, more concerns about a slowdown in the manufacturing industry put pressure on stocks. The Shanghai index didn't move much, but one key ETF tracking the Chinese market sank nearly 4% in response to the news, largely on weakness in telecom giant China Mobile (NYSE: CHL  ) , which plays a commanding role in many emerging market-focused ETFs.
  � Indian stocks suffered from some of the same macroeconomic issues, with the Bombay market's index down about 3% and ETF tracking the market falling 4% to 5%. The Indian finance minister responded to the decline, which many blamed on Fed Chair Ben Bernanke's comments, by saying, "We think that Bernanke's statement has been misunderstood or misinterpreted." Yet that didn't seem to appease investors in outward-directed industries like Infosys (NYSE: INFY  ) , whose IT offerings require health activity levels not just in India but in the U.S. and other customer-heavy countries as well.
  � Stocks in Mexico suffered declines of almost 5%, retracing some ground after an extraordinarily strong stretch of gains on optimism about the country's ability to reinvigorate its economy beyond its core reliance on petroleum and to resolve ongoing conflicts with drug cartels.

  But there were some relatively bright spots in other emerging markets. Brazilian stocks were actually up a bit on the week, as the nation found itself better insulated from all the happenings in Asia related to China and Japan. Russian stocks also remained relatively stable,

Top Safest Companies To Watch For 2014: Synergy Pharmaceuticals Inc (SGYP)

Synergy Pharmaceuticals, Inc., incorporated on February 11, 1992, is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal (GI), disorders and diseases. The Company�� lead product candidate is plecanatide, a guanylyl cyclase C (GC-C), receptor agonist, to treat GI disorders, primarily chronic constipation (CC), and constipation-predominant-irritable bowel syndrome (IBS-C). It is also developing SP-333, the second generation GC-C receptor agonist for the treatment of gastrointestinal inflammatory diseases, such as ulcerative colitis (UC). The Company�� active pharmaceutical ingredients (APIs) and the final formulated drug products are manufactured for it by third party contractors.

As of December 31, 2011, the Company was developing plecanatide, a synthetic hexadecapeptide designed to mimic the actions of the GI hormone uroguanylin, for the treatment of CC and IBS-C. Plecanatide is an agonist of GC-C receptor. As of December 31, 2011, the Company was dosing patients in an 800-patient Phase II/III clinical trial of plecanatide to treat. It is also developing a second generation GC-C receptor analog, SP-333, which is in pre-clinical development for the treatment of gastrointestinal inflammatory diseases. SP-333 is a synthetic analog of uroguanylin, a natriuretic hormone.

The Company competes with Ironwood Pharmaceuticals, Inc., Forest Laboratories, Inc., Takeda Pharmaceuticals America, Inc., Sucampo Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Shire Plc.

Advisors' Opinion:

• [By Monica Gerson]

  Breaking news

  Time Warner Cable (NYSE: TWC) reported a drop in its third-quarter profit. Time Warner Cable's quarterly profit fell to $532 million, or $1.84 per share, from $808 million, or $2.60 per share, in the year-ago period. To read the full news, click here. Synergy Pharmaceuticals (NASDAQ: SGYP) today announced the start of a phase 2 clinical trial to evaluate the safety and efficacy of SP-333, its second-generation GC-C agonist and once-daily oral treatment, in adult patients with opioid-induced constipation (OIC). To read the full news, click here. Cigna (NYSE: CI) reported a 19% rise in its third-quarter earnings and lifted its full-year earnings outlook. To read the full news, click here. Charm Communications (NASDAQ: CHRM) announced today that the special committee of the Company's board of directors, consisting of independent directors Mr. Zhan Wang, Mr. Andrew J. Rickards and Mr. Gang Chen, has retained China Renaissance Securities (Hong Kong) Limited as its financial advisor and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP as its legal advisor. To read the full news, click here.

  Posted-In: Bank of America US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

• [By Sean Williams]

  Finally, Synergy Pharmaceuticals (NASDAQ: SGYP  ) may have had the wildest week of them all. Synergy's share price spiked 16% on Tuesday as an analyst at Cantor Fitzgerald raised her peak sales estimate for plecanatide, the company's midstage drug for chronic idiopathic constipation and irritable bowel syndrome with constipation, to $1.58 billion from $1.05 billion, as clinical data has been stronger than expected. However, the company didn't return the favor to shareholders by -- the very next day, mind you ��announcing a secondary offering of 16.375 million shares. The downside of clinical-stage companies is the always apparent risk of dilution. Shares have lost 25% since their Tuesday close.

Top Safest Companies To Watch For 2014: Baltic Trading Limited (BALT)

Baltic Trading Limited engages in shipping business in the dry bulk industry spot market worldwide. The company operates a fleet of dry bulk ships that transport iron ore, coal, grain, steel products, and other dry bulk cargoes. Its fleet consists of 2 Capesize vessels, 4 Supramax vessels, and 3 Handysize vessels with an aggregate carrying capacity of approximately 672,000 deadweight tons. The company charters its vessels to trading houses, including commodities traders, as well as producers and government-owned entities. Baltic Trading Limited was founded in 2009 and is based in New York, New York.

Advisors' Opinion:

• [By Tim Melvin]

  Baltic Trading (BALT) got slammed by 17% last week as the Baltic Dry Index continued its decline. The global recovery is going to have fits and starts and the sector will be quite volatile. Baltic Trading works in the spot market for cargo like iron ore, coal, grain, and steel products so the stock price will likely jump around with the BDI reading.

• [By GuruFocus]

  George Soros (Trades, Portfolio) just reported his first quarter portfolio. He buys Citrix Systems Inc, Baker Hughes Inc, Comcast Corp, Spansion Inc, etc during the 3-months ended 03/31/2014, according to the most recent filings of his investment company, Soros Fund Management LLC. As of 03/31/2014, Soros Fund Management LLC owns 305 stocks with a total value of $10.1 billion. These are the details of the buys and sells.New Purchases: BHI, CODE, CTRP, CLI, AVB, COMM, CNQ, AGO, AUY, ATML, ASH, BXMT, CSTM, AEM, CMA, ARE, CHKP, AUQ, BEAV, CX, ADSK, AALCP, BLK, AIG, BIIB, ADEP, AMRI, ARWR, ATHX, BALT, BCRX, BEAT, CFX, CLFD, CUR, CODE,Added Positions: CTXS, CMCSA, CNP, ALTR, BRCD, CBS, CRM, CHTR, CCJ, CIEN, BIDU, ALLE, ABT, CDNS, ACT,Reduced Positions: AAPL, CCI, AMT, ABBV, AAL, BITA, AL, ANGI, ARIA, CBST, BA, BIRT, EXAR,Sold Out: C, BAC, CRI, AMZN, AGN, CF, BRCM, COTY, BMY, AMCX, CAR, A, ADBE, AFL,For the details of George Soros (Trades, Portfolio)'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=George+SorosThis is the sector weightings of his portfolio:Technology18.9%Energy14%Healthcare8.3%Consumer Defensive8.2%Communication Services8.1%Consumer Cyclical5.4%Industrials5.1%Basic Materials4.9%Financial Services2.5%Real Estate1.9%Utilities0.5%These are the top 5 holdings of George Soros (Trades, Portfolio)1. Teva Pharmaceutical Industries Ltd (TEVA) - 10,310,041 shares, 5.4% of the total portfolio. Shares added by 10.67%2. Herbalife Ltd (HLF) - 4,901,337 shares, 2.8% of the total portfolio. Shares added by 52.9%3. EQT Corp (EQT) - 2,573,814 shares, 2.5% of the total portfolio. Shares added by 3.27%4. Adecoagro SA (AGRO) - 25,915,076 shares, 2.1% of the total portfolio.5. Halliburton Co (HAL) - 3,596,353 shares, 2.1% of the total portfolio. Shares reduced by 20.73%New Purchase: Baker Hughes Inc (BHI)George Soros (Trades, Portfolio) initiated holdings in Baker Hughes Inc. His purchase prices were between $51.82 and $65.27, with an estimated